Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
Keywords: cDNA; cDNA; complementary DNA; FI; fold increase; hs-CRP; high-sensitivity C-reactive protein; IL-1; interleukin 1; IL-6; interleukin 6; IL-1Ra; IL-1 receptor antagonist; IMM; indolent multiple myeloma; ISR; injection site reaction; MGUS; monoclonal gammopathy